The anti-inflammatory potency of dexamethasone is determined by the route of application in vivo

Immunology Letters

Volumn 129, Issue 1, 2010, Pages 50-52

  Weichhart, Thomas ^a   Brandt, Oliver ^b   Lassnig, Caroline ^c   Müller, Mathias ^c   Hörl, Walter H ^a   Stingl, Georg ^b   Säemann, Marcus D ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Allergy and Infectious Diseases DIAID   (Austria)

^c UNIVERSITY OF VETERINARY MEDICINE   (Austria)

Author keywords

Contact hypersensitivity; Dexamethasone; Endotoxin shock; Glucocorticoids; Inflammation

Indexed keywords

DEXAMETHASONE; ENDOTOXIN; LIPOPOLYSACCHARIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; BAGG ALBINO MOUSE; C57BL 6 MOUSE; CONTACT ALLERGY; CONTROLLED STUDY; DOSE RESPONSE; DRUG ADMINISTRATION ROUTE; DRUG DOSE COMPARISON; DRUG MEGADOSE; DRUG POTENCY; DRUG TREATMENT FAILURE; IN VIVO STUDY; LETHALITY; LETTER; LOW DRUG DOSE; MOUSE; NONHUMAN; OTITIS; PRIORITY JOURNAL; TREATMENT RESPONSE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; DERMATITIS, CONTACT; DEXAMETHASONE; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DRUG ADMINISTRATION ROUTES; ENDOTOXEMIA; IMMUNITY; INFLAMMATION; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; OXAZOLONE;

EID: 77649193168     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2009.12.025     Document Type: Letter

References (18)

1. Rhen T., and Cidlowski J.A. Antiinflammatory action of glucocorticoids-new mechanisms for old drugs. N Engl J Med 353 (2005) 1711-1723
2. Mager D.E., Moledina N., and Jusko W.J. Relative immunosuppressive potency of therapeutic corticosteroids measured by whole blood lymphocyte proliferation. J Pharm Sci 92 (2003) 1521-1525
3. Tuckermann J.P., Kleiman A., Moriggl R., Spanbroek R., Neumann A., Illing A., et al. Macrophages and neutrophils are the targets for immune suppression by glucocorticoids in contact allergy. J Clin Invest 117 (2007) 1381-1390
4. Sternberg E.M. Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens. Nat Rev Immunol 6 (2006) 318-328
5. Perretti M., and D'Acquisto F. Annexin A1 and glucocorticoids as effectors of the resolution of inflammation. Nat Rev Immunol 9 (2009) 62-70
6. Liberman A.C., Druker J., Garcia F.A., Holsboer F., and Arzt E. Intracellular molecular signaling. Basis for specificity to glucocorticoid anti-inflammatory actions. Ann N Y Acad Sci 1153 (2009) 6-13
7. Taube M., and Carlsten H. Action of dexamethasone in the suppression of delayed-type hypersensitivity in reconstituted SCID mice. Inflamm Res 49 (2000) 548-552
8. Chatterjee S., Premachandran S., Shukla J., and Poduval T.B. Synergistic therapeutic potential of dexamethasone and l-arginine in lipopolysaccharide-induced septic shock. J Surg Res 140 (2007) 99-108
9. Xu T., Qiao J., Zhao L., He G., Li K., Wang J., et al. Effect of dexamethasone on acute respiratory distress syndrome induced by the H5N1 virus in mice. Eur Respir J 33 (2009) 852-860
10. Liu M.L., Lee Y.P., Wang Y.F., Lei H.Y., Liu C.C., Wang S.M., et al. Type I interferons protect mice against enterovirus 71 infection. J Gen Virol 86 (2005) 3263-3269
11. Yu Z., Ohtaki Y., Kai K., Sasano T., Shimauchi H., Yokochi T., et al. Critical roles of platelets in lipopolysaccharide-induced lethality: effects of glycyrrhizin and possible strategy for acute respiratory distress syndrome. Int Immunopharmacol 5 (2005) 571-580
12. Sadikot R.T., Jansen E.D., Blackwell T.R., Zoia O., Yull F., Christman J.W., et al. High-dose dexamethasone accentuates nuclear factor-kappa b activation in endotoxin-treated mice. Am J Respir Crit Care Med 164 (2001) 873-878
13. Frode-Saleh T.S., and Calixto J.B. Synergistic antiinflammatory effect of NF-kappaB inhibitors and steroidal or non steroidal antiinflammatory drugs in the pleural inflammation induced by carrageenan in mice. Inflamm Res 49 (2000) 330-337
14. Rabbani F., Myers A., Ramey E., Ramwell P., and Penhos J. Acute protection against arachidonate toxicity by hydrocortisone and dexamethasone in mice. Prostaglandins 21 (1981) 699-704
15. Han S.J., Choi J.H., Ko H.M., Yang H.W., Choi I.W., Lee H.K., et al. Glucocorticoids prevent NF-kappaB activation by inhibiting the early release of platelet-activating factor in response to lipopolysaccharide. Eur J Immunol 29 (1999) 1334-1341
16. Gentile D.M., Tomlinson E.S., Maggs J.L., Park B.K., and Back D.J. Dexamethasone metabolism by human liver in vitro. Metabolite identification and inhibition of 6-hydroxylation. J Pharmacol Exp Ther 277 (1996) 105-112
17. Garbrecht M.R., Schmidt T.J., Krozowski Z.S., and Snyder J.M. 11Beta-hydroxysteroid dehydrogenase type 2 and the regulation of surfactant protein A by dexamethasone metabolites. Am J Physiol Endocrinol Metab 290 (2006) E653-E660
18. Diederich S., Hanke B., Burkhardt P., Muller M., Schoneshofer M., Bahr V., et al. Metabolism of synthetic corticosteroids by 11 beta-hydroxysteroid-dehydrogenases in man. Steroids 63 (1998) 271-277